RACK1

Small ribosomal subunit protein RACK1 · P63244 · RACK1 on Sugi Atlas →

0 patent compounds predicted against RACK1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RACK1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia PHASE4COMPLETED
Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit PHASE2/PHASE3WITHDRAWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas PHASE2SUSPENDED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer PHASE1/PHASE2COMPLETED
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment PHASE1COMPLETED
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer EARLY_PHASE1COMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases nanNOT_YET_RECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Protein Intake and Step Reduction in Older Adults nanCOMPLETED
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy nanRECRUITING
Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Intermittent Fasting for Pancreatitis nanNOT_YET_RECRUITING
Immune Cell Response to Stimuli nanRECRUITING
Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation nanCOMPLETED
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RACK1 binder may also engage these)

ProteinNameSimilarity
P63247 1.000 P63247 →
Q93134 1.000 Q93134 →
P63246 1.000 P63246 →
G1SJB4 1.000 G1SJB4 →
Q4R7Y4 1.000 Q4R7Y4 →
P68040 1.000 P68040 →
O42249 1.000 O42249 →
P63245 0.999 P63245 →
P63243 0.999 P63243 →
O42248 0.998 O42248 →
O18640 0.996 O18640 →
P25387 0.996 P25387 →
Q01369 0.994 Q01369 →
G4MQX3 0.993 G4MQX3 →
A0A223GEB2 0.992 A0A223GEB2 →
P49026 0.991 P49026 →
Q39836 0.990 Q39836 →
Q9C4Z6 0.990 Q9C4Z6 →
Q25189 0.988 Q25189 →
P93340 0.986 P93340 →
O24456 0.986 O24456 →
Q9LV28 0.984 Q9LV28 →
O24076 0.984 O24076 →
Q39336 0.983 Q39336 →
Q21215 0.982 Q21215 →
Q10281 0.980 Q10281 →
P49027 0.980 P49027 →
Q6L4F8 0.979 Q6L4F8 →
P83774 0.978 P83774 →
P69104 0.974 P69104 →